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VPS35 leaves endosomes lost in transition
S
luggish recycling 
of a protein-slicing 
enzyme could pro-
mote Alzheimer’s disease 
(AD), Wen et al. show.
A, the protein that 
accumulates in the brains 
of AD patients, is formed 
when enzymes cut up its 
parental protein, known as amyloid precursor protein. One of 
those enzymes is -secretase or BACE1. BACE1 cycles between 
the Golgi apparatus and the plasma membrane, traveling through 
endosomes on the way. A protein complex called the retromer 
helps transport proteins from endosomes to the Golgi. Previous 
studies have found reduced levels of two retromer components, 
including the protein VPS35, in the brains of AD patients.
To fi nd out whether VPS35 affects AD, the team crossed 
two mouse lines to create animals that are prone to many AD 
symptoms and generate half the normal amount of VPS35. The 
mice displayed AD-like abnormalities earlier than their parental 
strains, and their brains accumulated more A.
Cells lacking VPS35 carried extra BACE1 in their 
endosomes. BACE1 is more active in the acidic interior of 
endosomes than in the more basic surroundings of the Golgi 
apparatus. Thus, by leaving more BACE1 trapped in endosomes, 
the decline in VPS35 levels could spur the formation of more A. 
Although no VPS35 mutations have so far turned up in AD 
patients, the protein’s level in the brain dwindles with age in mice. 
The researchers suspect that certain AD risk factors, such as 
oxidative stress, also diminish VPS35 levels in the brain.
Wen, L., et al. 2011. J. Cell Biol. http://dx.doi.org/10.1083/
jcb.201105109.
The actomyosin ring bulks up
C
alvert et al. reveal 
that large fungal 
cells have more 
myosin II associated with 
their contractile rings 
than do smaller cells, 
which allows them to 
constrict the ring faster 
during cytokinesis.
A recent study of C. 
elegans embryos showed that the time required for the contractile 
ring to close during cytokinesis was about the same no matter 
the size of the cell, which means the ring must tighten faster in 
larger cells. Scientists have been keen to test whether girth affects 
constriction rate in other species. The obstacle has been fi  nding 
organisms whose dividing cells differ enough in size.
Calvert et al. recognized a candidate for such a study—
the fungus Neurospora crassa. Its filaments, or hyphae, can 
vary up to fourfold in diameter and undergo a process called 
septation that’s somewhat akin to mitosis.
As in nematodes, the ring closed faster in larger hyphae. But 
N. crassa differed from nematodes in a couple of ways. In N. crassa, 
the contractile rings of larger cells started out with more myosin II 
than the rings of smaller cells, which could drive faster constriction. 
Indeed, reducing the amount of ring-associated myosin II slowed 
the rate of constriction. In addition, the amount of myosin II in the 
ring remained constant as the ring tightened, instead of declining 
as in nematodes. Therefore, in N. crassa, the design and mechanics 
of the contractile ring vary with size. Future studies will investigate 
whether the same relationship holds in other species.
Calvert, M.E.K., et al. 2011. J. Cell Biol. http://dx.doi.org/10.1083/
jcb.201101055.
Purple in this heat map indicates that 
there is more myosin II in a larger 
contractile ring (left) than in a smaller 
one (right).
HPK1 tones down the T cell receptor
L
ike a fire alarm 
that keeps ringing 
after the blaze is 
out, the T cell receptor 
(TCR) can cause prob-
lems if it continues trans-
mitting signals. Lasserre 
et al. clarify the intricate 
mechanism that turns off 
the receptor.
The TCR detects pathogens and enlists the adaptive immune 
system to combat the invaders. On the surface of a T cell, TCR 
molecules huddle with several other kinds of proteins to form sig-
naling microclusters. However, prolonged signaling can prompt 
autoimmune attacks, so cells need a way to disperse the micro-
clusters. Previous work suggested that the protein kinase HPK1 
inhibits T cell signaling by phosphorylating a key microcluster 
adaptor called SLP76, spurring it to bind to members of the 
14-3-3 protein family. But how HPK1’s actions turned down TCR 
signaling remained unclear.
Lasserre et al. showed that HPK1 slips into microclusters 
and breaks them up. To join a microcluster, SLP76 fi  rst hooks up 
with the protein GADS, which connects to another protein, LAT, 
that admits the pair to the microcluster. HPK1 phosphorylated 
not only SLP76 but also GADS, prompting both molecules to 
link up with 14-3-3 proteins. In turn, the 14-3-3 proteins force 
SLP76 and GADS to separate from LAT, breaking up the micro-
cluster and curbing signaling. In the future, researchers will need 
to work out the mechanism that adjusts HPK1 activity under nor-
mal and pathological conditions. Mice and humans lacking the 
protein are prone to autoimmune diseases, suggesting that it may 
be a promising target for drugs to treat these illnesses.
Lasserre, R., et al. 2011. J. Cell Biol. http://dx.doi.org/10.1083/
jcb.201103105.
Relative to control cells (left), cells short 
on VPS35 (right) accumulate more 
BACE1 (red) in endosomes (green). 
Cells with a normal version of HPK1 
(left) carry fewer microclusters (green 
spots) than does a cell with a faulty 
version of HPK1 (right).